beta-solamarine has been researched along with Lung Neoplasms in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Han, L; Li, J; Tang, Q; Wang, R; Wang, S; Wang, X; Wu, W; Xu, M; Yang, X; Zhou, Q | 1 |
| Chai, X; Hann, SS; He, C; Li, L; Liu, Z; Tang, Q; Wu, J; Zheng, F | 1 |
| Hann, SS; Li, L; Tang, Q; Wu, J; Xiao, Q; Zheng, F | 1 |
| Hann, S; Li, L; Tang, Q; Wang, Z; Wu, W; Zhang, F; Zhao, S; Zhou, Y | 1 |
| Chen, Y; Hann, SS; Tang, Q; Xiao, Q; Yang, L | 1 |
| Chang, LC; Huang, YS; Kuo, KW; Liang, CH; Liu, LF; Shiu, LY | 1 |
| Kuo, KW; Liang, CH; Lin, CC; Lin, WL; Liu, LF; Shiu, LY | 1 |
| Chang, LC; Kuo, KW; Liang, CH; Sheu, HM; Shiu, LY | 1 |
| Chang, LC; Kuo, KW; Liang, CH; Sheu, HM; Shiu, LY; Tsai, EM | 1 |
9 other study(ies) available for beta-solamarine and Lung Neoplasms
| Article | Year |
|---|---|
Solamargine enhanced gefitinib antitumor effect via regulating MALAT1/miR-141-3p/Sp1/IGFBP1 signaling pathway in non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Insulin-Like Growth Factor Binding Protein 1; Lung Neoplasms; MicroRNAs; Protein Kinase Inhibitors; RNA, Long Noncoding; Signal Transduction | 2023 |
Novel reciprocal interaction of lncRNA HOTAIR and miR-214-3p contribute to the solamargine-inhibited PDPK1 gene expression in human lung cancer.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; Animals; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice, Nude; MicroRNAs; RNA, Long Noncoding; Solanaceous Alkaloids | 2019 |
Combination of Solamargine and Metformin Strengthens IGFBP1 Gene Expression Through Inactivation of Stat3 and Reciprocal Interaction Between FOXO3a and SP1.
Topics: A549 Cells; Animals; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Forkhead Box Protein O3; Gene Expression; Humans; Immunohistochemistry; Insulin-Like Growth Factor Binding Protein 1; Lung Neoplasms; Metformin; Mice; Mice, Nude; Phosphorylation; Promoter Regions, Genetic; RNA Interference; RNA, Small Interfering; Signal Transduction; Solanaceous Alkaloids; Sp1 Transcription Factor; STAT3 Transcription Factor; Transplantation, Heterologous | 2017 |
Targeting signal transducer and activator of transcription 3 contributes to the solamargine-inhibited growth and -induced apoptosis of human lung cancer cells.
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Humans; Lung Neoplasms; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Solanaceous Alkaloids; STAT3 Transcription Factor | 2014 |
Targeting EP4 downstream c-Jun through ERK1/2-mediated reduction of DNMT1 reveals novel mechanism of solamargine-inhibited growth of lung cancer cells.
Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Feedback, Physiological; Female; Humans; Lung Neoplasms; Mice, Nude; Molecular Targeted Therapy; Phosphorylation; Proto-Oncogene Proteins c-jun; Receptors, Prostaglandin E, EP4 Subtype; Solanaceous Alkaloids | 2017 |
Action of solamargine on TNFs and cisplatin-resistant human lung cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cisplatin; DNA, Neoplasm; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; Solanaceous Alkaloids; Tumor Necrosis Factor-alpha | 2004 |
Action of solamargine on human lung cancer cells--enhancement of the susceptibility of cancer cells to TNFs.
Topics: Antineoplastic Agents, Phytogenic; Cell Division; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; Solanaceous Alkaloids | 2004 |
Solamargine upregulation of Fas, downregulation of HER2, and enhancement of cytotoxicity using epirubicin in NSCLC cells.
Topics: Antibiotics, Antineoplastic; Antigens, Neoplasm; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; DNA Topoisomerases, Type II; DNA-Binding Proteins; Down-Regulation; Drug Synergism; Epirubicin; fas Receptor; Gene Expression Regulation, Neoplastic; Genes, erbB-2; Humans; Lung Neoplasms; Poly-ADP-Ribose Binding Proteins; RNA, Messenger; Solanaceous Alkaloids; Up-Regulation | 2007 |
Solamargine enhances HER2 expression and increases the susceptibility of human lung cancer H661 and H69 cells to trastuzumab and epirubicin.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, Neoplasm; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; DNA Topoisomerases, Type II; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Combinations; Drug Screening Assays, Antitumor; Drug Synergism; Epirubicin; Gene Expression Regulation, Neoplastic; Genes, erbB-2; Humans; Lung Neoplasms; Poly-ADP-Ribose Binding Proteins; Solanaceous Alkaloids; Trastuzumab; Up-Regulation | 2008 |